Template:Moexipril: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...")
 
(Replaced content with "__NOTOC__ {{Moexipril}} '''''For patient information about Moexipril, click here.''''' {{SB}} Univasc<sup>®</sup> ==References== {...")
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
__NOTOC__
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Moexipril|{{fontcolor|#6C7B8B|Moexipril}}]]'''''
{{Moexipril}}
|-
 
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | UNIVASC<sup>®</sup> FDA Package Insert
'''''For patient information about Moexipril, click [[Moexipril (patient information)|here]].'''''
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril indications and usage|Indications and Usage]]
{{SB}} Univasc<sup>®</sup>
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril dosage and administration|Dosage and Administration]]
==References==
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril contraindications|Contraindications]]
{{Reflist|2}}
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril warnings and precautions|Warnings and Precautions]]
[[Category:Cardiovascular Drugs]]
|-
[[Category:Drugs]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril adverse reactions|Adverse Reactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril drug interactions|Drug Interactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril use in specific populations|Use in Specific Populations]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril description|Description]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril clinical pharmacology|Clinical Pharmacology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril clinical studies|Clinical Studies]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril how supplied storage and handling|How Supplied/Storage and Handling]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril patient counseling information|Patient Counseling Information]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Moexipril
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|}

Revision as of 15:38, 14 April 2014


Template loop detected: Template:Moexipril

For patient information about Moexipril, click here.

Synonyms / Brand Names: Univasc®

References

For patient information about Moexipril, click here.

Synonyms / Brand Names: Univasc®

References